Nolvadex

PMID: 30050469

Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing.

Rouhimoghadam Milad, Safarian Shahrokh, Carroll Jason S et al.

Frontiers in physiology · 2025

PMID: 37240924

An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management.

Khallouki Farid, Hajji Lhoussain, Saber Somayya et al.

Journal of personalized medicine · 2023

PMID: 32814527

Antimicrobial, Antitumor and Side Effects Assessment of a Newly Synthesized Tamoxifen Analog.

Abdmouleh Fatma, El Arbi Mehdi, Saad Hajer Ben et al.

Current topics in medicinal chemistry · 2021

PMID: 28635978

Vaginal Testosterone for Management of Aromatase Inhibitor-Related Sexual Dysfunction: An Integrative Review.

Lemke Emily A, Madsen Lydia T, Dains Joyce E

Oncology nursing forum · 2018

PMID: 27428472

The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients.

Zeidan B, Anderson K, Peiris L et al.

Breast (Edinburgh, Scotland) · 2017

PMID: 25378122

Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment.

Günaldı Meral, Erkisi Melek, Afşar Ciğdem Usul et al.

Pharmacology · 2015

PMID: 22786516

Toremifene versus tamoxifen for advanced breast cancer.

Mao Chen, Yang Zu-Yao, He Ben-Fu et al.

The Cochrane database of systematic reviews · 2012

PMID: 21402610

Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.

Nichols Hazel B, Berrington de González Amy, Lacey James V et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011

PMID: 20554203

How can Nolvadex abolish arthralgia in women taking newer generic Tamoxifen preparations?

Sahin Ilyas, Ararat Erhan, Altundag Kadri

Breast (Edinburgh, Scotland) · 2011

PMID: 21460130

Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.

Kitzmiller Joseph P, Groen David K, Phelps Mitch A et al.

Cleveland Clinic journal of medicine · 2011

PMID: 19944537

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.

van de Velde C J H, Verma S, van Nes J G H et al.

Cancer treatment reviews · 2010

PMID: 20347307

The use of Nolvadex in the treatment of generic Tamoxifen-associated small joint arthralgia.

Blencowe N S, Reichl C, Gahir J et al.

Breast (Edinburgh, Scotland) · 2010

PMID: 19149613

Targeted therapies in solid tumours: pinpointing the tumour's Achilles heel.

Kornek Gabriela, Selzer Edgar

Current pharmaceutical design · 2009

PMID: 18072256

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.

Buzdar Aman U, Coombes R Charles, Goss Paul E et al.

Cancer · 2008

PMID: 16870082

Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.

Buzdar Aman, Chlebowski Rowan, Cuzick Jack et al.

Current medical research and opinion · 2007

PMID: 17138220

Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.

Jonat Walter, Gnant Michael, Boccardo Francesco et al.

The Lancet. Oncology · 2007

PMID: 16467121

Adjuvant endocrine therapy for postmenopausal women with early breast cancer.

Ingle James N

Clinical cancer research : an official journal of the American Association for Cancer Research · 2006

PMID: 16685245

Raloxifene (Evista) for breast cancer prevention in postmenopausal women.

The Medical letter on drugs and therapeutics · 2006